Pulmonology
From the Journals
Young vapers and smokers beware: Eye problems abound
Use of both cigarettes and vapes is apparently much worse for eye health than either product use alone, a new study found.
Article
Mepolizumab improves asthma after 1 year despite comorbidities
Patients with asthma and comorbid chronic rhinosinusitis with nasal polyps showed especially significant benefits.
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
Guidelines
ACR releases guideline for managing ILD in patients with rheumatic disease
“Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD....
From the Journals
Interstitial lung disease plus pulmonary hypertension equals poor outcomes in systemic sclerosis
Female sex and higher body mass index were associated with lower mortality risk.
Conference Coverage
Expert calls for sparing oxygen use for dyspnea in the emergency department
Oxygen therapy is used too often in patients with respiratory difficulties, says one expert.
Feature
Dupilumab gains off-label uses as clinicians turn to drug for more indications
As the roster of approved and off-label indications grows, skin specialists said, pediatricians and other primary care providers should become...
From the Journals
Healthy babies can still get very sick from RSV
The study challenges the assumption that only infirm children are at risk for the worst outcomes from RSV.
News from the FDA/CDC
FDA warns AstraZeneca over ‘misleading claims’ about COPD drug
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
Conference Coverage
GERD with bronchiectasis: New invasive interventions show benefit
Invasive interventions show promise in the adjunctive control of bronchiectasis and other lung diseases with GERD.
Feature
AI in pulmonary medicine – imaging and beyond
Emerging artificial intelligence tools in pulmonology are crunching electronic records and physiological signals to improve predictive models.